Pilot Test of a Mobile App That Helps Spanish-speakers Find Mental Health Services in the US.
September 25, 2024 updated by: Volver Health
Rumbo: an Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals
The goal of this observational study is to develop and test a mobile app for Spanish speakers residing in the US who seeking drug treatment and/or behavioral health services for themselves or an associate. The main questions it aims to answer are:
What are the features and content needed on this app?
How will people use and share this app?
Will they connect with treatment services?
After receiving input from focus group participants and other community stakeholders, the app was made available and its usage was tracked to determine its long-term, broad-scale feasibility.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
13
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87112
- Volver Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Hispanic/Latine community sample
Description
Inclusion Criteria:
- At least 18 years old
- Identify as Hispanic/Latino
- Own a smartphone, pad, or computer
- Be willing to meet with study personnel more than once
Exclusion Criteria:
- Age less than 18 or more than 75
- Evidence of significant cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Focus Group
The group consisted of three subgroups of Spanish-speakers: women, men, and caretakers.
|
"Rumbo" is an easily shared bi-lingual application that helps Hispanic individuals with unhealthy substance use find and access treatment services and related resources.
The application stands out from other eHealth tools by leveraging the collective efficacy of the Hispanic community to overcome barriers and support individuals' self-efficacy for engaging the treatment system.
Rumbo's simple, user-centered design provides less-acculturated Hispanic individuals with a culturally appropriate tool to understand their needs within the complex US treatment system.
Rumbo is comprised of four innovations: (1) a sharing function that facilitates its own implementation among the target population; (2) culturally responsive content and design; (3) problem identification and treatment navigation enhanced to include related resources; (4) an API that is designed for interoperability across extant technologies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale
Time Frame: From enrollment to the close of end-user testing after 4 weeks.
|
The system usability scale (SUS) is a ten-item attitude scale giving a global view of subjective assessments of usability.
|
From enrollment to the close of end-user testing after 4 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: William P Campbell, Volver Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
April 2, 2024
Study Completion (Actual)
April 2, 2024
Study Registration Dates
First Submitted
September 16, 2024
First Submitted That Met QC Criteria
September 25, 2024
First Posted (Actual)
October 1, 2024
Study Record Updates
Last Update Posted (Actual)
October 1, 2024
Last Update Submitted That Met QC Criteria
September 25, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- R43DA057759 (U.S. NIH Grant/Contract)
- 1R43DA057759-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data from participants will be reported when the study is published ion a peer-reviewed journal.
IPD Sharing Time Frame
Upon publication in the Spring of 2025, and available indefinitely after that.
IPD Sharing Access Criteria
Anyone with access to academic journals may access the data.
Also, anyone may write to the study authors to receive a free copy of the published report.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.